Arun Pandiri

Staff Scientist

National Institute of Environmental Health Sciences
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Year:

2025

Year:

2025

Lung cancer, the leading cause of cancer mortality, exhibits diverse histologic subtypes and genetic complexities. Numerous preclinical mouse models have been developed to study lung cancer, but data from these models are disparate, siloed, and difficult to compare in a centralized fashion. In this study, we established the Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB), an extensive repository of 1,354 samples from 77 transcriptomic datasets covering 974 samples from genetically engineered mouse models (GEMM), 368 samples from carcinogen-induced models, and 12 samples from a spontaneous model. Meticulous curation and collaboration with data depositors produced a robust and comprehensive database, enhancing the fidelity of the genetic landscape it depicts. The LCAMGDB aligned 859 tumors from GEMMs with human lung cancer mutations, enabling comparative analysis and revealing a pressing need to broaden the diversity of genetic aberrations modeled in the GEMMs. To accompany this resource, a web application was developed that offers researchers intuitive tools for in-depth gene expression analysis. With standardized reprocessing of gene expression data, the LCAMGDB serves as a powerful platform for cross-study comparison and lays the groundwork for future research, aiming to bridge the gap between mouse models and human lung cancer for improved translational relevance. Significance: The Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB) provides a comprehensive and accessible resource for the research community to investigate lung cancer biology in mouse models.

Year:

2025

The cancer hazard associated with lifetime exposure to radiofrequency radiation (RFR) was examined in Sprague Dawley (SD) rats at the Ramazzini Institute (RI), Italy. There were increased incidences of gliomas and cardiac schwannomas. The translational relevance of these rare rat tumors for human disease is poorly understood. We examined the genetic alterations in RFR-derived rat tumors through molecular characterization of important cancer genes relevant for human gliomagenesis. A targeted next-generation sequencing (NGS) panel was designed for rats based on the top 23 orthologous human glioma-related genes. Single-nucleotide variants (SNVs) and small insertion and deletions (indels) were characterized in the rat gliomas and cardiac schwannomas. Translational relevance of these genetic alterations in rat tumors to human disease was determined through comparison with the Catalogue of Somatic Mutations in Cancer (COSMIC) database. These data suggest that rat gliomas resulting from life-time exposure to RFR histologically resemble low grade human gliomas but surprisingly no mutations were detected in rat gliomas that had homology to the human IDH1 p.R132 or IDH2 p.R172 suggesting that rat gliomas are primarily wild-type for IDH hotspot mutations implicated in human gliomas. The rat gliomas appear to share some genetic alterations with IDH1 wildtype human gliomas and rat cardiac schwannomas also harbor mutations in some of the queried cancer genes. These data demonstrate that targeted NGS panels based on tumor specific orthologous human cancer driver genes are an important tool to examine the translational relevance of rodent tumors resulting from chronic/life-time rodent bioassays.

Year:

2024

Year:

2023

Year:

2023

Collaborators (24)

Kekoa Taparra

Assistant Professor

University of California, Los Angeles

UNITED STATES
View details

John Minna

Professor and Direcdtor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Vassilis Aidinis

Biomedical Sciences Research Center Alexander Fleming

GREECE
View details

Barbara Grüner

University Hospital Essen

GERMANY
View details

Phuoc T. Tran

University of Maryland

UNITED STATES
View details

Pawel Mazur

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Roger A. Moorehead

University of Guelph

CANADA
View details

Ralph J. DeBerardinis

University of Texas Southwestern Medical Center

UNITED STATES
View details

Charles Rudin

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

J. Edward van Veen

Assistant Adjunct Professor

University of California, Los Angeles

UNITED STATES
View details

Takeshi Izawa

Associate Professor/Research Professor

Osaka University

JAPAN
View details

George Acquaah-Mensah

Professor of Pharmaceutical Sciences

Massachusetts College of Pharmacy and Health Sciences

UNITED STATES
View details

Yonathan Lissanu

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Trudy G. Oliver

Duke University

UNITED STATES
View details

YING GAO

University of Texas Southwestern Medical Center

UNITED STATES
View details

David MacPherson

Professor

Fred Hutch Cancer Center

UNITED STATES
View details

Giorgio Ramadori

Scientific Collaborator

University of Geneva

SWITZERLAND
View details

Rosanna Martinelli

Professor of Molecular Biology

Università degli Studi di Napoli Federico II

ITALY
View details

Min Gyu Lee

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Shyam Biswal

Professor

Johns Hopkins University

UNITED STATES
View details

CHARLES POWELL

Division Chief/Professor of Medicine

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Jennifer Beane-Ebel

Assistant Professor

Boston University School of Medicine

UNITED STATES
View details

Guanghua Xiao

-

UNITED STATES
View details

Yang Xie

Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details